Advanced Oxygen Technologies, Inc. (AOXY) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
ADVANCED OXYGEN TECHNOLOGIES, INC. RANDOLPH, VT 05060 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 65 - Real Estate (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 108 | 101 | 105 | ||||||
| Cash and cash equivalent | 108 | 101 | 105 | ||||||
| Receivables | 1 | 1 | 1 | ||||||
| Other undisclosed current assets | 89 | 96 | 106 | ||||||
| Total current assets: | 89 | 96 | 106 | 109 | 102 | 106 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 605 | 580 | 584 | 599 | 572 | 592 | |||
| Total noncurrent assets: | 605 | 580 | 584 | 599 | 572 | 592 | |||
| TOTAL ASSETS: | 694 | 675 | 691 | 709 | 674 | 698 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 86 | 75 | 70 | 71 | 67 | 63 | |||
| Accounts payable | 8 | 1 | 1 | 2 | 6 | ||||
| Accrued liabilities | 78 | 74 | 69 | 69 | 62 | 63 | |||
| Debt | 127 | 127 | 127 | 129 | 7 | ||||
| Other liabilities | 3 | ||||||||
| Other undisclosed current liabilities | 112 | 131 | 149 | 150 | 153 | 147 | |||
| Total current liabilities: | 326 | 206 | 346 | 348 | 350 | 220 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 127 | 127 | |||||||
| Total noncurrent liabilities: | 127 | 127 | |||||||
| Total liabilities: | 326 | 333 | 346 | 348 | 350 | 347 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 368 | 342 | 345 | 360 | 324 | 351 | |||
| Common stock | 33 | 33 | 33 | 33 | 33 | 33 | |||
| Additional paid in capital | 21,057 | 21,057 | 21,057 | 21,057 | 21,057 | 21,057 | |||
| Accumulated other comprehensive income (loss) | 39 | 9 | 14 | 32 | (0) | 23 | |||
| Accumulated deficit | (20,761) | (20,757) | (20,759) | (20,762) | (20,765) | (20,762) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total equity: | 368 | 342 | 345 | 360 | 324 | 351 | |||
| TOTAL LIABILITIES AND EQUITY: | 694 | 675 | 691 | 709 | 674 | 698 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11 | 11 | 11 | 11 | 11 | 11 | ||
| Sales-type lease, revenue | 11 | 11 | 11 | |||||
| Gross profit: | 11 | 11 | 11 | 11 | 11 | 11 | ||
| Operating expenses | (13) | (6) | (5) | (6) | (11) | 23 | ||
| Other undisclosed operating income (loss) | (0) | 0 | ||||||
| Operating income (loss): | (2) | 5 | 5 | 5 | (1) | 34 | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 0 | (0) | 1 | |||||
| Interest and debt expense | 0 | (0) | (0) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (2) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (2) | 5 | 5 | 3 | (1) | 34 | ||
| Other undisclosed income from continuing operations before income taxes | 0 | 2 | ||||||
| Income (loss) from continuing operations before income taxes: | (2) | 5 | 5 | 5 | (1) | 34 | ||
| Income tax expense | (2) | (2) | (3) | (2) | (2) | (2) | ||
| Income (loss) from continuing operations: | (4) | 3 | 3 | 3 | (3) | 32 | ||
| Other undisclosed net loss | (0) | |||||||
| Net income (loss): | (4) | 3 | 3 | 3 | (3) | 32 | ||
| Other undisclosed net income (loss) attributable to parent | 0 | (29) | ||||||
| Net income (loss) available to common stockholders, diluted: | (4) | 3 | 3 | 3 | (3) | 3 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (4) | 3 | 3 | 3 | (3) | 32 | ||
| Comprehensive income (loss): | (4) | 3 | 3 | 3 | (3) | 32 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 31 | (6) | (18) | 33 | (23) | (28) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 26 | (3) | (16) | 36 | (26) | 4 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.